Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage MalignanciesHarjeet Singh, Laurence J.N. Cooper|Cancer Research|2011Cited by 199
Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting CellsHarjeet Singh, Laurence J.N. Cooper|PLoS ONE|2013Cited by 171